ProShares Ultra Nasdaq Biotechnology (BIB)

Assets	$97.42M
Expense Ratio	0.95%
PE Ratio	n/a
Shares Out	1.45M
Dividend (ttm)	$0.34
Dividend Yield	0.53%
Ex-Dividend Date	Jun 26, 2024
Payout Ratio	n/a
1-Year Return	+20.92%

Volume	17,687
Open	65.16
Previous Close	65.28
Day's Range	64.47 - 65.29
52-Week Low	40.10
52-Week High	69.07
Beta	1.57
Holdings	225
Inception Date	Apr 8, 2010

About BIB

Fund Home Page

The ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. BIB was launched on Apr 8, 2010 and is issued by ProShares.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NASDAQ
• Ticker Symbol: BIB
• ETF Provider: ProShares
• Index Tracked: NASDAQ / Biotechnology

Top 10 Holdings

152.05% of assets

Name	Symbol	Weight
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	n/a	53.66%
NASDAQ BIO INDEX SWAP BNP	n/a	34.59%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	n/a	25.25%
NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL	n/a	6.69%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	n/a	6.12%
Gilead Sciences, Inc.	GILD	5.48%
Regeneron Pharmaceuticals, Inc.	REGN	5.27%
Amgen Inc.	AMGN	5.26%
Vertex Pharmaceuticals Incorporated	VRTX	5.24%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	n/a	4.49%

Dividends

Ex-Dividend	Amount	Pay Date
Jun 26, 2024	$0.26476	Jul 3, 2024
Mar 20, 2024	$0.04032	Mar 27, 2024
Dec 20, 2023	$0.03839	Dec 28, 2023
Dec 22, 2022	$0.01985	Dec 30, 2022
Sep 21, 2010	$0.011	Sep 28, 2010